Koyfin Home > Directory > Health Care > Acceleron Pharma > Net Income Margin

Acceleron Pharma Net Income Margin Chart (XLRN)

Acceleron Pharma annual/quarterly Net Income Margin from 2012 to 2020. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Acceleron Pharma Net Income Margin for the quarter ending June 06, 2020 was $-46m a -2,222.86% increase of 1,032m year over year
  • Acceleron Pharma Net Income Margin for the last 12 months ending June 06, 2020 was $-158m a -124.00% increase of 196m year over year
  • Acceleron Pharma Annual Net Income Margin for 2019 was $-169m a -403.50% increase of 681m from 2018
  • Acceleron Pharma Annual Net Income Margin for 2018 was $-850m a 5.31% decrease of -45m from 2017
  • Acceleron Pharma Annual Net Income Margin for 2017 was $-804m a 74.48% decrease of -599m from 2016
Other Margins & Efficiency Metrics:
  • Acceleron Pharma EBITDA Margin for the quarter ending March 03, 2016 was $-20m a -39.99% increase of 8m year over year
  • Acceleron Pharma Return on Capital % for the quarter ending September 09, 2018 was -23.05 a 14.16% decrease of -3.26 year over year
  • Acceleron Pharma Return on Equity % for the quarter ending September 09, 2018 was -35.54 a 13.15% decrease of -4.68 year over year
View Chart On Koyfin

Quarterly XLRN Net Income Margin Data

06/2020$-46m
03/2020$-1,173m
12/2019$-60m
09/2019$-1,078m
06/2019$-65m
03/2019$-1,369m
12/2018$-910m
09/2018$-889m
06/2018$-785m
03/2018$-811m

Annual XLRN Net Income Margin Data

2019$-169m
2018$-850m
2017$-804m
2016$-205m
2015$-353m
2014$-350m
2013$-38m
2012$-214m
2011$45m